文献速递支持与姑息治疗

接受阿片类药物治疗癌痛患者非医疗阿片使用行为的发生率及相关因素

Frequency of and Factors Associated With Nonmedical Opioid Use Behavior Among Patients With Cancer Receiving Opioids for Cancer Pain.
PubMed 文献 · JAMA Oncol · 2021-01-01

该预后研究纳入1554例在MD Anderson癌症中心接受阿片类药物治疗癌痛的癌症患者,评估非医疗阿片使用(NMOU)行为的发生率及独立预测因素。结果显示19.2%的患者出现至少1种NMOU行为,中位随访8周内发生;未婚/离异、SOAPP评分>7、疼痛程度较高及吗啡等效日剂量(MEDD)较高与NMOU行为独立相关。

要点

  • 19.2%的癌痛患者在开始阿片治疗后中位8周内出现至少1种NMOU行为。
  • 未婚或离异、SOAPP评分>7、疼痛评分高及MEDD高是NMOU行为的独立预测因素。
  • 77%的NMOU行为发生在首次随访后的前2次随访内,需早期监测。

核心结论

  • 接受阿片类药物治疗癌痛的患者中,19.2%出现至少1种NMOU行为,中位发生时间为初始支持治疗咨询后8周。
  • 未婚或离异、SOAPP评分阳性、较高疼痛评分及较高MEDD与NMOU行为独立相关。

研究设计与样本

  • 预后研究,纳入2016年3月18日至2018年6月6日转诊至MD Anderson癌症中心支持治疗中心的3615例癌症患者。
  • 最终分析1554例连续患者,均因癌痛使用阿片类药物至少1周,并完成Edmonton症状评估量表、SOAPP和CAGE-AID问卷。
  • 排除无3个月内随访、未完成问卷或无计划阿片治疗的患者。

主要发现

  • 299例(19.2%)患者出现1种或以上NMOU行为,每例患者NMOU行为数中位为1(IQR 1-3)。
  • 745次NMOU行为中576次(77%)发生在首次随访后的前2次随访内。
  • 最常见的NMOU行为是为不当补药而计划外就诊(218/745,29%)。

关键数值与推荐

  • 递归分区分析显示,未婚、MEDD>50 mg及SOAPP评分>7与NMOU行为较高风险(56%)相关。

临床怎么用

  • 对癌痛患者启动阿片治疗时,应评估婚姻状态、SOAPP评分、疼痛程度及MEDD以识别NMOU高风险患者。
  • NMOU行为多发生在治疗早期(前2次随访内),建议在初始阶段加强监测和随访。
  • 对高风险患者可考虑减少阿片暴露、加强随访或实施筛查干预。

局限性

  • 单中心研究,患者来自支持治疗中心,可能存在选择偏倚。
  • NMOU行为基于既定诊断标准评估,可能存在漏报或误分类。
  • 中位随访时间较短(8周),长期NMOU行为发生率未明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: One of the main aims of research on nonmedical opioid use (NMOU) is to reduce the frequency of NMOU behaviors through interventions such as universal screening, reduced opioid exposure, and more intense follow-up of patients with elevated risk. The absence of data on the frequency of NMOU behavior is the major barrier to conducting research on NMOU. OBJECTIVE: To determine the overall frequency of and the independent predictors for NMOU behavior. DESIGN, SETTING, AND PARTICIPANTS: In this prognostic study, 3615 patients with cancer were referred to the supportive care center at MD Anderson Cancer Center from March 18, 2016, to June 6, 2018. Patients were eligible for inclusion if they had cancer and were taking opioids for cancer pain for at least 1 week. Patients were excluded if they had no follow-up within 3 months of initial consultation, did not complete the appropriate questionnaire, or did not have scheduled opioid treatments. After exclusion, a total of 1554 consecutive patients were assessed for NMOU behavior using established diagnostic criteria. All patients were assessed using the Edmonton Symptom Assessment Scale, the Screener and Opioid Assessment for Patients with Pain (SOAPP), and the Cut Down, Annoyed, Guilty, Eye Opener-Adapted to Include Drugs (CAGE-AID) survey. Data were analyzed from January 6 to September 25, 2020. RESULTS: A total of 1554 patients (median [interquartile range (IQR)] age, 61 [IQR, 52-69] years; 816 women [52.5%]; 1124 White patients [72.3%]) were evaluable for the study, and 299 patients (19.2%) had 1 or more NMOU behaviors. The median (IQR) number of NMOU behaviors per patient was 1 (IQR, 1-3). A total of 576 of 745 NMOU behaviors (77%) occurred by the first 2 follow-up visits. The most frequent NMOU behavior was unscheduled clinic visits for inappropriate refills (218 of 745 [29%]). Eighty-eight of 299 patients (29.4%) scored 7 or higher on SOAPP, and 48 (16.6%) scored at least 2 out of 4 points on the CAGE-AID survey. Results from the multivariate model suggest that marital status (single, hazard ratio [HR], 1.58; 95% CI, 1.15-2.18; P = .005; divorced, HR, 1.43; 95% CI, 1.01-2.03; P = .04), SOAPP score (positive vs negative, HR, 1.35; 95% CI, 1.04-1.74; P = .02), morphine equivalent daily dose (MEDD) (HR, 1.003; 95% CI, 1.002-1.004; P < .001), and Edmonton Symptom Assessment Scale pain level (HR, 1.11; 95% CI, 1.06-1.16; P < .001) were independently associated with the presence of NMOU behavior. In recursive partition analysis, single marital status, MEDD greater than 50 mg, and SOAPP scores greater than 7 were associated with a higher risk (56%) for the presence of NMOU behavior. CONCLUSIONS AND RELEVANCE: This prognostic study of patients with cancer taking opioids for cancer pain found that 19% of patients developed NMOU behavior within a median duration of 8 weeks after initial supportive care clinic consultation. Marital status (single or divorced), SOAPP score greater than 7, higher levels of pain severity, and MEDD level were independently associated with NMOU behavior. This information will assist clinicians and investigators designing clinical and research programs in this important field.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Yennurajalingam S, Arthur J, Reddy S, et al. Frequency of and Factors Associated With Nonmedical Opioid Use Behavior Among Patients With Cancer Receiving Opioids for Cancer Pain. JAMA Oncol. 2021. PMID: 33410866. doi:10.1001/jamaoncol.2020.6789

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。